Histology and Cytology Market : Current Analysis and Forecast (2022-2030)
Emphasis on Examination Type (Histology and Cytology (Breast Cancer, Cervical Cancer, and Others); Test Type (Microscopy Tests, Molecular Genetics Tests, And Flow Cytometry]; Product Type [Instruments & Analysis Software System, and Consumable & Reagents); End-users [Hospitals & Clinical Diagnostics, Academic & Research Institutes, and Other); Region/Country
Histology and Cytology Market was valued at USD 13,100.8 million in 2021 & is expected to grow at a CAGR of 12.4% from 2022-2028. Moreover, With the increasing demand for the detection of cell and tissue characteristics and an increase in the occurrence of cell-based disorders like cancer around the world. The advantage of the quick interpretation of primary diagnostic data is provided by the incorporation of digital solutions to the cytological diagnosis. Additionally, businesses are introducing cutting-edge digital cytology devices that will help with the quick on-site screening of cytology samples and further help in better observation in histology testing of the disease. There are many diagnostics that are working to improve technological advancement to better examine the disease. For instance, in June 2021, Antech Diagnostics introduced a Digital Cytology Scanner in North America. This scanner makes it possible to offer whole-slide interpretations in under two hours, which helps shorten examination times and evaluate plenty of samples in POC situations.
Some of the major players operating in the market include Abbott; BD, Merck KGaA, F. Hoffmann-La Roche Ltd; Hologic, Inc.; Sysmex Corporation; Danaher; Trivitron Healthcare; Thermo Fisher Scientific Inc; Agilent Technologies, Inc. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst examination type, the histology segment has a considerable share of the market in 2021.”
Based on examination type, the histology and cytology market are segmented into Histology and Cytology (Breast Cancer, Cervical Cancer, and Others). Amongst these, the histology segment will attain a considerable share of the market during the forecast period. This is because due to the rising geriatric population, increasing research activities, and government initiatives and funding towards healthcare infrastructure, research and development, and cancer screening programs have contributed to the growth of the histology segment.
“Amongst product type, the Instruments & Analysis Software will attain the fastest growth in the market during the forecast period.”
Based on product type, the histology and cytology market are bifurcated into Instruments & Analysis Software System, and Consumable & Reagents. Among these, the instruments & analysis software system segment will attain fastest growth in the market during forecast period owing to the use of advanced tools like multimodal nonlinear microscopy, photoacoustic microscopy, and stimulated Raman spectroscopy for histopathology has been increasing. However, the adoption of large-scale digital solutions in the pathology industry has been hindered by high infrastructure costs and technical limitations.
“North America is expected to lead the market share during the forecast period.”
The North American market for histology and cytology is expanding due to various reasons. One of the main factors driving this growth is the escalating occurrence of chronic illnesses, including cancer, in the region. The American Cancer Society reported approximately 1.8 million new cancer cases in the United States in 2020, making histology and cytology critical tools in diagnosing and treating cancer. Alongside the increased prevalence of cancer, progress in histology and cytology technology has also played a role in the market’s expansion. Advancements such as digital pathology solutions and automated tissue processing systems have resulted in faster and more precise processes, which has led to greater adoption of these technologies in North America.
Histology And Cytology Market Report Coverage
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
Customization Options:
The global histology and cytology market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to contact us to get a report that completely suits your requirements.
Table of Contents
Research Methodology for the Histology and Cytology Market Analysis (2022-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global histology and cytology market were the three major steps undertaken to create and analyze the adoption of industrial relay in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global histology and cytology market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the histology and cytology market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the histology and cytology market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as examination type, test type, product type and end-user. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the histology and cytology market. Further, we conducted factor analysis using dependent and independent variables such as examination type, test type, product type and end-user of the histology and cytology market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the histology and cytology market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global histology and cytology market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the histology and cytology market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global histology and cytology market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global histology and cytology market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the examination type, test type, product type and end-user in the global histology and cytology market.
The main objective of the Global Histology and Cytology Market Study
The current & future market trends of the global histology and cytology market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the histology and cytology market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments.
- Segments in the study include areas of the examination type, test type, product type and end-user.
- Defining and analysis of the regulatory framework for the industrial relay
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
- Analyze the current and forecast market size of the histology and cytology market for the major region.
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
- Company profiles of the histology and cytology market and the growth strategies adopted by the market players to sustain in the fast-growing market.
- Deep dive regional level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
